Roche (Japan)

Recent papers from Roche (Japan)

1. Transitioning from anonymous to real-name genetic testing in Japan: Implementation and implications for medical safetyJournal of Community Genetics · 2026
2. Clinical Organizational Science: an integrative framework for structural intervention in complex organizationsSHILAP Revista de lepidopterología · 2026
3. Current status and challenges in HER2 IHC assessment: scoring survey results in JapanBreast Cancer Research and Treatment · 2024
4. Clinical evaluation of a fully automated and high-throughput molecular testing system for detection of influenza virusVirology Journal · 2022
5. Comparing the cobas Influenza A/B Nucleic acid test for use on the cobas Liat System (Liat) with rapid antigen tests for clinical management of Japanese patients at the point of carePLoS ONE · 2022
6. Comparison between a new assay system, Elecsys® Anti‑p53, and conventional MESACUP™ for the detection of serum anti‑p53 antibodies: A multi‑institutional studyMolecular and Clinical Oncology · 2022
7. Clinical evaluation of the cobas® MTB-RIF/INH reagent and the cobas® 6800 for the detection of isoniazid and rifampicin resistanceTuberculosis · 2022
8. Clinical Performance of the cobas Liat SARS-CoV-2 & Influenza AB for the Detection of SARS-CoV-2 in Nasal Samples2022
9. Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in JapanRetrovirology · 2020
10. PIK3CAmutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive early breast cancerOncotarget · 2018
11. Age‐specific serum anti‐Müllerian hormone concentration in Japanese women and its usefulness as a predictor of the ovarian responseReproductive Medicine and Biology · 2017
12. A case of familial dysalbuminemic hyperthyroxinemia (FDH) in Japan: FDH as a possible differential diagnosis of syndrome of inappropriate secretion of thyroid-stimulating hormone (SITSH)Endocrine Journal · 2016
13. Improved protocol for extraction of genomic DNA from formalin-fixed paraffin-embedded tissue samples without the use of xyleneClinical Chemistry and Laboratory Medicine (CCLM) · 2016
14. Expression of proteins associated with adipocyte lipolysis was significantly changed in the adipose tissues of the obese spontaneously hypertensive/NDmcr-cp ratDiabetology & Metabolic Syndrome · 2014
15. Characteristics and Outcomes of HCV Genotype-1-Infected Patients Treated with Peginterferon and Ribavirin Combination Therapy with Discordant HCV Responses 4 and 12 Weeks after Starting TherapyIntervirology · 2014
16. Improvement and evaluation of a 1,2-dioleoylglycerol method for measuring pancreatic lipase catalytic activity in serumClinical Chemistry and Laboratory Medicine (CCLM) · 2014
17. Potential impact of combined high‐ and low‐risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2Journal of obstetrics and gynaecology research · 2013
18. Albumin concentration determined by the modified bromocresol purple method is superior to that by the bromocresol green method for assessing nutritional status in malnourished patients with inflammationAnnals of Clinical Biochemistry International Journal of Laboratory Medicine · 2013
19. Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirinBMC Infectious Diseases · 2012
20. Baseline factors and early viral response (week 4) to antiviral therapy with peginterferon and ribavirin for predicting sustained virologic response in patients infected with hepatitis C virus genotype 1: A multicenter studyJournal of Medical Virology · 2012